Clinical Trial Update: Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease [NA]

View source ↗

Summary

This ClinicalTrials.gov update reports the completion of a study evaluating transcutaneous auricular neurostimulation to reduce heavy menstrual bleeding in pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding
• Von Willebrand Disease

Drugs mentioned

• Transcutaneous auricular neurostimulation device

Snippet

Sponsor: Five Liters, Inc. | Conditions: Von Willebrand Disease, Type 1, Heavy Menstrual Bleeding | NA | Status: COMPLETED